WHTM updated their numbers following the recent upgrade. They have reported FY13 NPAT at $8.8m. Using weighted average shares on issue for FY13 gives reported EPS of around 24.5cps.
For FY14 they are forecasting:
Revenue 88.0
EBITDA 27.5
EBIT 19.7
NPAT 13.9
EPS 29.0cps
Note WHTM is the house broker for TTN
- Forums
- ASX - By Stock
- AUK
- short term future
AUK
aumake limited.
Add to My Watchlist
0.00%
!
0.2¢

short term future, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.046M |
Open | High | Low | Value | Volume |
0.2¢ | 0.2¢ | 0.2¢ | $936 | 467.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
24 | 16935650 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 4183028 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
24 | 16935650 | 0.002 |
15 | 51950275 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 4183028 | 8 |
0.004 | 7370558 | 16 |
0.005 | 18714234 | 8 |
0.006 | 12471833 | 6 |
0.007 | 12346926 | 7 |
Last trade - 12.38pm 26/06/2025 (20 minute delay) ? |
Featured News
AUK (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online